Clinical Literature Summaries presented by InpharmD™ (S4))-logo

Clinical Literature Summaries presented by InpharmD™ (S4))

Health & Wellness Podcasts

Season-4 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.

Season-4 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.

Location:

United States

Description:

Season-4 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.

Language:

English


Episodes

Can Evusheld Increase Cardiovascular Events?

9/26/2022
Tune in as we discuss the PROVENT trial and the on-going TACKLE trial to determine whether or not Evusheld can increase cardiovascular events.

Duration:00:04:48

Could Intermittent Fasting be the Next Big Weight Loss Tool?

6/21/2022
A randomized clinical trial conducted to assess time-restricted eating with calorie restriction as compared with daily calorie restriction alone for the effects on weight loss and metabolic risk factors in obese patients.

Duration:00:04:30

A 4th Dose of the COVID-19 Vaccine

4/29/2022
A regression analysis conducted in Israel showed that a fourth dose appeared to increase the protection against severe illness relative to three doses that were administered more than 4 months earlier. Further studies are needed before applying this to a larger population.

Duration:00:05:47

A Possible Alternative for Recurrent Urinary Tract Infections

4/21/2022
A multicenter, randomized, open label, non-inferiority trial conducted to test and compare the efficacy of methenamine hippurate for prevention of recurrent urinary tract infections (UTI) with the current standard prophylaxis of daily low dose antibiotics.

Duration:00:05:43

Estimation of Breast Cancer Overdiagnosis

3/25/2022
A cohort study conducted to estimate the rate of breast cancer overdiagnosis in contemporary mammography practice accounting for the detection of nonprogressive cancer.

Duration:00:04:56

Can Ketamine Treat Acute, Severe Suicidal Ideation?

3/14/2022
A prospective, double blind, superiority, randomized placebo-controlled trial conducted to confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks.

Duration:00:04:49

Could SER-109 be an Answer for Recurrent C.Difficile Infection?

2/22/2022
A phase 3, double-blind, randomized, placebo-controlled trial conducted to show superiority of SER-109 in reducing the risk of C. difficile infection recurrence up to 8 weeks after treatment.

Duration:00:05:11

To Boost or not to Boost - That is the Question

2/11/2022
A retrospective study conducted to assess for any decrease in mortality associated with the use of the BNT162b2 (BioNTech, Pfizer vaccine) booster.

Duration:00:05:37

Old Dogs Can Learn New Tricks: Is Outpatient Remdesivir a Game Changer against Omicron?

1/20/2022
A double-blind, randomized, placebo-controlled trial conducted to evaluate the efficacy and safety of a 3-day course of remdesivir in high-risk, non-hospitalized patients with COVID-19.

Duration:00:06:25

Can Financial Incentives Help Pregnant Patients Quit Smoking?

1/6/2022
A single-blind, multicenter, randomized, controlled trial conducted to evaluate the efficacy of financial incentives dependent on continuous smoking abstinence on smoking cessation and birth outcomes among pregnant smokers.

Duration:00:05:08

Milvexian for the Prevention of Venous Thromboembolism

12/22/2021
An open-label, randomized, parallel-group, adaptive design with blinded outcome adjudication trial conducted to compare the efficacy and safety of milvexian and enoxaparin in patients undergoing elective knee arthroplasty.

Duration:00:08:16

Merck's New COVID-19 Pill - Molnupiravir

12/1/2021
The first in-human, phase 1, randomized, double-blind, placebo-controlled study conducted to determine the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of molnupiravir in healthy subjects.

Duration:00:05:21

Can chlorthalidone therapy improve blood-pressure control in patients with advanced CKD?

11/25/2021
A double-blind, randomized, placebo-controlled trial conducted to assess the role of chlorthalidone for hypertension in advanced chronic kidney disease.

Duration:00:07:02

Does the Addition of Vasopressin and Methylprednisolone Improve Outcomes in Patients with In-Hospital Cardiac Arrest?

11/17/2021
An investigator-initiated, multi-center, randomized, double-blind, superiority, placebo-controlled conducted to determine whether the combination of vasopressin and methylprednisolone administered during in-hospital cardiac arrest improves return of spontaneous circulation.

Duration:00:06:11

Can fluvoxamine prevent COVID-19 related hospitalization?

11/10/2021
A randomized, adaptive, platform trial conducted to assess the efficacy of fluvoxamine versus placebo in preventing hospitalization (defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19).

Duration:00:05:54

Can MDMA Treat Post-Traumatic Stress Disorder?

11/3/2021
A randomized, double-blind, placebo-controlled, phase 3 study, conducted to evaluate the efficacy and safety MDMA-assisted therapy for PTSD compared with placebo with therapy?

Duration:00:08:26

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

9/28/2021
A randomized, double-blind, parallel-group, placebo-controlled, event-driven trial conducted to evaluate the effects of SGLT2 inhibition with empagliflozin on major heart failure outcomes in patients with heart failure and a preserved ejection fraction.

Duration:00:07:32

Functional Neurological Disorder after COVID-19 Vaccination

9/17/2021
This week, InpharmD looks at two case reports discussing presentations of patients who developed Functional Neurological Disorder (FND) after receiving COVID-19 vaccination.

Duration:00:06:31

Myocarditis after COVID-19 Vaccination

9/9/2021
This week, we look at two different case reports: 1) Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 2) Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination Tune in to learn more!

Duration:00:06:01

World Trade Center Dust Exposure and Hepatic Steatosis

9/3/2021
A cohort study conducted to determine whether there is a dose–response relationship between the intensity of exposure to the World Trade Center (WTC) site and the risk of hepatic steatosis (HS) in the WTC General Responder Cohort (GRC).

Duration:00:06:50